-

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Icosavax; Is the Deal in the Best Interest of Shareholders?

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Icosavax, Inc. (NASDAQ: ICVX) breached their fiduciary duties in connection with the proposed sale of the Company to AstraZeneca.

You can click or copy and paste the following link to join this investigation:

https://www.johnsonfistel.com/investigations/Icosavax-co

On November 30, 2023, Icosavax announced that it had entered a deal to merge with AstraZeneca. Under the terms of the deal, Icosavax shareholders will receive $15.00 per share in cash at closing, plus a non-tradable contingent value right to receive up to $5.00 in cash, payable upon achievement of specified regulatory and net sales milestones.

Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given a one Wall Street analyst has a $30.00 price target on the stock. If you are a shareholder of Icosavax and believe the proposed buyout price is too low or you're interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

About Johnson Fistel, LLP:

Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.

Johnson Fistel, LLP is a shareholder rights law firm representing individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information, visit their website http://www.johnsonfistel.com.

Attorney advertising.

Past results do not guarantee future outcomes.

Services may be performed by attorneys in any of our offices.

Contacts

Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

Industry:

Johnson Fistel, LLP

NASDAQ:ICVX
Release Versions
English

Contacts

Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

More News From Johnson Fistel, LLP

Datavault AI Inc. Class Action Lawsuit Alert: Johnson Fistel Notifies Investors of October 5, 2026 Lead Plaintiff Deadline

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors in Datavault AI Inc. (NASDAQ: DVLT). The Datavault AI class action lawsuit seeks to represent investors who purchased or otherwise acquired Datavault AI securities between September 4, 2024 and October 30, 2025, both dates inclusive (the “Class Period”). Investors are hereby notified that they have until October 5, 2026, to move the Court t...

Johnson Fistel Investigates New Blaize Holdings Disclosures Following 68% Revenue Guidance Cut

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating whether Blaize Holdings, Inc. (NASDAQ: BZAI) or certain of its executive officers violated federal securities laws in connection with the company’s revenue guidance and disclosures concerning customer agreements, purchase orders, accounts receivable, and pipeline metrics. What if I purchased Blaize securities? If you purchased Blaize securities and suffered investment losses, you may be eligible to participate in Johnson Fistel’s...

Jefferies Financial Group Inc. Shareholders Are Encouraged to Contact Johnson Fistel Regarding Potential Recovery of Investment Losses

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating whether Jefferies Financial Group Inc. (NYSE: JEF) or certain of its executive officers violated federal securities laws. The investigation concerns Jefferies’ disclosures regarding its exposure to First Brands Group through its asset-management operations and whether investors received materially accurate and complete information. What if I purchased Jefferies securities? If you purchased Jefferies securities and suffered invest...
Back to Newsroom